Literature DB >> 11976269

Effects of morphine and morphine withdrawal on brainstem neurons innervating hypothalamic nuclei that control the pituitary-adrenocortical axis in rats.

Maria Luisa Laorden1, Maria Teresa Castells, Maria Victoria Milanés.   

Abstract

Different data support a role for brainstem noradrenergic inputs to the hypothalamic paraventricular nucleus (PVN) in the control of hypothalamus - pituitary - adrenocortical (HPA) axis. However, little is known regarding the functional adaptive changes of noradrenergic afferent innervating the PVN and supraoptic nucleus (SON) during chronic opioid exposure and upon morphine withdrawal. Here we have studied the expression of Fos after administration of morphine and during morphine withdrawal in the rat hypothalamic PVN and SON. Fos production was also studied in brainstem regions that innervate hypothalamic nuclei: the nucleus of solitary tract (NTS - A2) and the ventrolateral medulla (VLM - A1) and combined with immunostaining for tyrosine hydroxylase (TH) for immunohistochemical identification of active neurons during morphine withdrawal. Male rats were implanted with s.c. placebo or morphine (tolerant/dependent) pellets for 7 days. On day 8 rats received an injection of saline i.p., morphine i.p., saline s.c. or naloxone s.c. Acute morphine administration produced an increase in Fos expression at hypothalamic nuclei and in the brainstem regions, and tolerance developed towards this effect. Precipitated morphine withdrawal induced marked Fos immunoreactivity within the PVN and SON. Concomitantly, numerous neurons in the brainstem were stimulated by morphine withdrawal. Moreover, catecholaminergic-positive neurons in the brainstem showed a significant increase in Fos expression in response to morphine withdrawal. These findings demonstrate that chronic activation of opioid receptors results in altered patterns of immediate-early genes (IEG) expression in the PVN and SON, which occurs concurrently with an increased activity of their inputs from the brainstem.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976269      PMCID: PMC1762112          DOI: 10.1038/sj.bjp.0704684

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

Review 1.  Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun.

Authors:  J I Morgan; T Curran
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

2.  Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.

Authors:  M L Laorden; M T Castells; M D Martínez; P J Martínez; M V Milanés
Journal:  Endocrinology       Date:  2000-04       Impact factor: 4.736

3.  Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection.

Authors:  P M Plotsky
Journal:  Endocrinology       Date:  1987-09       Impact factor: 4.736

4.  The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat.

Authors:  P E Sawchenko; L W Swanson
Journal:  Brain Res       Date:  1982-11       Impact factor: 3.252

5.  The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat.

Authors:  P E Sawchenko; L W Swanson
Journal:  J Comp Neurol       Date:  1983-08-01       Impact factor: 3.215

6.  Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat.

Authors:  D M Ignar; C M Kuhn
Journal:  J Pharmacol Exp Ther       Date:  1990-12       Impact factor: 4.030

7.  Chronic administration of morphine alters immediate-early gene expression in the forebrain of post-dependent rats.

Authors:  P S Frankel; R E Harlan; M M Garcia
Journal:  Brain Res       Date:  1999-07-24       Impact factor: 3.252

8.  Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat.

Authors:  L W Swanson; D M Simmons
Journal:  J Comp Neurol       Date:  1989-07-22       Impact factor: 3.215

9.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.

Authors:  L W Swanson; P E Sawchenko; J Rivier; W W Vale
Journal:  Neuroendocrinology       Date:  1983       Impact factor: 4.914

10.  Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus.

Authors:  E T Cunningham; P E Sawchenko
Journal:  J Comp Neurol       Date:  1988-08-01       Impact factor: 3.215

View more
  20 in total

1.  CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.

Authors:  Javier Navarro-Zaragoza; Cristina Núñez; Jessica Ruiz-Medina; M Luisa Laorden; Olga Valverde; M Victoria Milanés
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

2.  Glucocorticoid receptors participate in the opiate withdrawal-induced stimulation of rats NTS noradrenergic activity and in the somatic signs of morphine withdrawal.

Authors:  Javier Navarro-Zaragoza; Juana M Hidalgo; M Luisa Laorden; M Victoria Milanés
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

3.  Morphine withdrawal stress modulates lipopolysaccharide-induced interleukin 12 p40 (IL-12p40) expression by activating extracellular signal-regulated kinase 1/2, which is further potentiated by glucocorticoids.

Authors:  Subhas Das; Jennifer Kelschenbach; Richard Charboneau; Roderick A Barke; Sabita Roy
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

4.  Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal.

Authors:  Juan-Antonio Garcia-Carmona; Pilar Almela; Alberto Baroja-Mazo; M Victoria Milanes; M Luisa Laorden
Journal:  Psychopharmacology (Berl)       Date:  2011-09-21       Impact factor: 4.530

5.  Protein kinase C phosphorylates the cAMP response element binding protein in the hypothalamic paraventricular nucleus during morphine withdrawal.

Authors:  F Martín; L Mora; Ml Laorden; Mv Milanés
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

6.  Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.

Authors:  Pilar Almela; Manuela Cerezo; A González-Cuello; M Victoria Milanés; M Luisa Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-11-25       Impact factor: 3.000

7.  Effects of acute and chronic nicotine on catecholamine neurons of the nucleus of the solitary tract.

Authors:  Stephen J Page; Mingyan Zhu; Suzanne M Appleyard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-10-24       Impact factor: 3.619

8.  Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors.

Authors:  Ana González-Cuello; M Victoria Milanés; Manuel Aviles; M Luisa Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-13       Impact factor: 3.000

9.  Serotonin activates catecholamine neurons in the solitary tract nucleus by increasing spontaneous glutamate inputs.

Authors:  Ran Ji Cui; Brandon L Roberts; Huan Zhao; Mingyan Zhu; Suzanne M Appleyard
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

10.  Effects of U-50488H and U-50488H withdrawal on c-fos expression in the rat paraventricular nucleus. Correlation with c-fos in brainstem catecholaminergic neurons.

Authors:  Maria Luisa Laorden; Maria Teresa Castells; Maria Victoria Milanés
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.